SATURDAY MORNING, FEBRUARY 4, 2023
Didactic Sessions Begin @ 8:00 am Level B Ballroom 1 | Cliff Lodge, Snowbird, UT
TUMOR SESSIONS
| 8:00 - 8:15 am |
 Preliminary Results of a Prospective Trial of Feasibility and Safety of using Advanced Intraoperative MRI (iMRI) for Glioma Surgery.
|
| 8:15 - 8:20 am | Discussion |
| 8:20 - 8:35 am |
 High-grade glioma imaging volumes and survival: A single-institution analysis of 101 patients after resection using intraoperative MRI.
|
| 8:35 - 8:40 am | Discussion |
| 8:40 - 8:55 am |
 The Combination of a Novel RAF/MEK Clamp (avutometinib, VS-6766) and FAK Inhibitor (defactinib, VS-6063) Overcomes MAPK Pathway Inhibitor Resistance in Melanoma Brain Metastases.
|
| 8:55 - 9:00 am | Discussion |
| 9:00 - 9:20 am |
 Glioblastoma Presenting as IPH with Negative Pathology.
|
| 9:20 - 9:25 am | Discussion |
| 9:25 - 10:00 am |
 Clinical Imaging Biomarker Strategies for Neuro-Oncology Drug Development.
|
| 10:00 - 10:05 am | Discussion |
| 10:05-10:25 am |
 Early Experience with Gammatile for High Grade Gliomas.
|
| 10:25-10:30 am | Discussion |
| 10:30 - 11:15 am |
 Updates on Precision Medicine in Brain Tumors for Surgeons. KASDON LECTURER |
| 11:15-11:20 am | Discussion |
| 11:20 am | Adjourn |
SATURDAY AFTERNOON, FEBRUARY 4, 2023
TUMOR/SKULL BASE SESSIONS
| 4:00 - 4:15 pm |
 Stereotactic Radiosurgery for Non-small cell lung Brain Metastases before and after the Targeted Therapy Era.
|
| 4:15 - 4:20 pm | Discussion |
| 4:20 - 4:35 pm |
 Reprogrammed TCA Cycle Maintains a Stem-Like Epitranscriptome and Therapeutic Persistence in Glioblastoma Stem Cells.
|
| 4:35 - 4:40 pm | Discussion |
| 4:40 - 4:55pm |
 A Multicenter, Propensity Score–Matched Assessment of Endoscopic vs. Microscopic Approaches in the Management of Pituitary Adenomas.
|
| 4:55 - 5:00 pm | Discussion |
| 5:00 - 5:15 pm |
 Interaction Between iPSC-Derived GABAergic Organoids and Tumor cells in Organoid-Glioblastoma Chimeras Promotes Tumor Growth and Impairs Neural Differentiation.
|
| 5:15 - 5:20 pm | Discussion |
| 5:20 - 5:35 pm |
 Visual Outcomes in Spheno-Orbital Meningiomas: A 10-year Experience.
|
| 5:35 - 5:40 pm | Discussion |
| 5:40 - 5:55 pm |
 Factors Associated with Hearing Outcomes after a Middle Fossa Approach in 131 Consecutive Patients with Vestibular Schwannomas.
|
| 5:55 - 6:00 pm | Discussion |
| 6:00 - 6:30 pm |
 Proton Craniospinal Irradiation for Solid Tumor Leptomeningeal Metastasis.
|
| 6:30 - 6:40 pm | Discussion |
| 6:40 pm | Adjourn |
Contact Us
Lanette Dunbar Meeting Coordinator Health Science Center Bldg 550, 5th Floor 175 N. Medical Drive East Salt Lake City, UT 84132 Phone: 801-556-2539 Fax: 801-581-4385 Email: lanette.dunbar@hsc.utah.edu